[go: up one dir, main page]

PE20171082A1 - Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados - Google Patents

Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados

Info

Publication number
PE20171082A1
PE20171082A1 PE2017001086A PE2017001086A PE20171082A1 PE 20171082 A1 PE20171082 A1 PE 20171082A1 PE 2017001086 A PE2017001086 A PE 2017001086A PE 2017001086 A PE2017001086 A PE 2017001086A PE 20171082 A1 PE20171082 A1 PE 20171082A1
Authority
PE
Peru
Prior art keywords
composition
weight
omega
fatty acids
lysine
Prior art date
Application number
PE2017001086A
Other languages
English (en)
Inventor
Gunter Knaup
Milan Latinovic
Michael Schwarm
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20171082(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of PE20171082A1 publication Critical patent/PE20171082A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085—Substances of natural origin of unknown constitution, f.i. plant extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se refiere a un proceso para aumentar la estabilidad hacia la oxidacion de una composicion que comprende acidos grasos omega-6 poliinsaturados que comprende las siguientes etapas: (i) proporcionar una composicion de partida que comprende al menos un componente acido graso omega-6 poliinsaturado; (ii) proporcionar una composicion de lisina; (iii) mezclar soluciones acuosas, acuoso-alcoholicas o alcoholicas de composicion de partida y composicion de lisina, y someter posteriormente la mezcla resultante a condiciones de secado por pulverizacion, formando asi una composicion de producto solido que comprende al menos una sal de un cation derivado de lisina con un anion derivado a partir de un acido graso omega-6 poliinsaturado; la composicion del producto que presenta un contenido de disolvente SC seleccionado entre los siguientes: SC <5% en peso, SC <3% en peso, SC <1 %en peso, SC <0.5% en peso. Dichos compuestos obtenibles son utiles en el tratamiento de cancer
PE2017001086A 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados PE20171082A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199976 2014-12-23

Publications (1)

Publication Number Publication Date
PE20171082A1 true PE20171082A1 (es) 2017-08-03

Family

ID=52344990

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017001086A PE20171082A1 (es) 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados

Country Status (24)

Country Link
US (1) US20170367394A1 (es)
EP (1) EP3236783B1 (es)
JP (1) JP6714000B2 (es)
KR (1) KR20170094789A (es)
CN (1) CN107105693B (es)
AU (1) AU2015371457B2 (es)
BR (1) BR112017013445B1 (es)
CA (1) CA2969157C (es)
CL (1) CL2017001613A1 (es)
CO (1) CO2017005849A2 (es)
DK (1) DK3236783T3 (es)
ES (1) ES2776393T3 (es)
IL (1) IL252482B (es)
MX (1) MX391057B (es)
MY (1) MY190506A (es)
PE (1) PE20171082A1 (es)
PH (1) PH12017501144B1 (es)
PL (1) PL3236783T3 (es)
RU (1) RU2706072C2 (es)
SA (1) SA517381762B1 (es)
SG (1) SG11201704399RA (es)
TW (1) TWI693893B (es)
WO (1) WO2016102316A1 (es)
ZA (1) ZA201704821B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11622952B2 (en) 2017-08-15 2023-04-11 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
US20220287345A1 (en) * 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
US20220280388A1 (en) 2019-08-08 2022-09-08 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
MX2022001570A (es) * 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
CA3146542A1 (en) 2019-08-08 2021-02-11 Ashish Guha Method of preparing a solid dosage form and a lubricant
EP4097201A4 (en) * 2020-01-30 2024-01-24 Silicycle Inc. METHOD FOR PREPARING A SOLID FORM OF BASIC AMINO ACID SALTS OF POLYUNSATURATED FATTY ACIDS
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant
CN111635306B (zh) * 2020-06-12 2022-09-27 上海海益环保科技有限公司 一种芥酸复合稳定剂及制备稳定芥酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
EP1564278B1 (en) * 2002-11-22 2018-01-10 Nippon Suisan Kaisha, Ltd. Composition containing organic substance having double bond with improved oxidation stability
WO2004112777A1 (ja) * 2003-06-20 2004-12-29 Mochida Pharmaceutical Co., Ltd. 下肢静脈瘤予防・治療用組成物
US20080311255A1 (en) * 2005-02-02 2008-12-18 Dsm Ip Assets B.V. Powder Compositions
US20140199313A1 (en) * 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
NZ573327A (en) * 2006-06-05 2012-07-27 Ocean Nutrition Canada Ltd Microcapsules with improved shells
US20080026109A1 (en) * 2006-06-29 2008-01-31 Martek Biosciences Corporation Sweetened Oil Compositions and Methods of Making
KR20150126977A (ko) * 2007-11-01 2015-11-13 엔지모테크 리미티드 유아 영양을 위한 지질 혼합물
US8609138B2 (en) * 2010-06-30 2013-12-17 Mochida Pharmaceutical Co., Ltd. ω3 fatty acid compound preparation

Also Published As

Publication number Publication date
RU2706072C2 (ru) 2019-11-13
DK3236783T3 (da) 2020-04-27
IL252482A0 (en) 2017-07-31
CA2969157C (en) 2024-05-28
ZA201704821B (en) 2019-06-26
AU2015371457A1 (en) 2017-06-22
SA517381762B1 (ar) 2020-10-27
PH12017501144B1 (en) 2024-02-21
RU2017125963A (ru) 2019-01-24
JP6714000B2 (ja) 2020-06-24
MY190506A (en) 2022-04-26
TWI693893B (zh) 2020-05-21
NZ732380A (en) 2024-03-22
PH12017501144A1 (en) 2018-03-05
PL3236783T3 (pl) 2020-06-15
RU2017125963A3 (es) 2019-06-18
CN107105693B (zh) 2021-04-02
WO2016102316A1 (en) 2016-06-30
KR20170094789A (ko) 2017-08-21
CA2969157A1 (en) 2016-06-30
US20170367394A1 (en) 2017-12-28
CL2017001613A1 (es) 2018-01-12
EP3236783A1 (en) 2017-11-01
MX391057B (es) 2025-03-21
SG11201704399RA (en) 2017-07-28
CO2017005849A2 (es) 2017-09-20
BR112017013445A2 (pt) 2018-06-26
JP2018501790A (ja) 2018-01-25
TW201639463A (zh) 2016-11-16
CN107105693A (zh) 2017-08-29
MX2017008274A (es) 2017-10-02
EP3236783B1 (en) 2020-02-05
ES2776393T3 (es) 2020-07-30
AU2015371457B2 (en) 2020-04-23
BR112017013445B1 (pt) 2021-11-23
IL252482B (en) 2021-08-31

Similar Documents

Publication Publication Date Title
PE20171083A1 (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-3 poliinsaturados
PE20171082A1 (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados
CL2020002269A1 (es) Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433)
CL2019002663A1 (es) Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201702448)
CY1120314T1 (el) Ζωοτροφη και μια διαδικασια για την παρασκευη της
CU24410B1 (es) Benzimidazol-2-aminas como inhibidores de midh1
BR112018009885A2 (pt) produção de derivados de olefina graxos através de metátese de olefina
EA201591954A1 (ru) Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций
AR097954A1 (es) Material de relleno tratado, composiciones que lo contienen y artículos preparados a partir del mismo
BR112017019749A2 (pt) processo de emulsificação em duas etapas para preparar fórmula para lactentes
BR112014031051A2 (pt) processo para produção de uma composição contendo folistatina ativa
RU2015113638A (ru) Кристаллическое вещество и содержащий его фармацевтический препарат
BR112016025931A8 (pt) composição de barra de sabão extrudada, barra e método para intensificar a transparência das barras de sabão
CO6590210A1 (es) Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
CL2016001375A1 (es) Composición, que comprende agente bioactivo (inmunógeno) dispersado en gotitas de aceite, polímero de recubrimiento entérico, un polímero mucoadhesivo, su método de preparación y uso para la administración oral de un agente bioactivo.
MX372559B (es) Método para fabricar ácido furan-2,5-dicarboxílico (fdca) a partir de una solución de sal.
AR095333A1 (es) Composiciones nutricionales que contienen un componente peptídico y método para reducir la incidencia de enfermedad autoimune
AR090554A1 (es) Compuestos de acido bencen-policarboxilico
AR097148A1 (es) Composición alimenticia para rumiantes y método para prepararla
AR094882A1 (es) Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
WO2015147705A3 (ru) Способ приготовления стерильной наноэмульсии перфторорганических соединений
RU2011150458A (ru) Способ приготовления кормового продукта
AR097142A1 (es) Composición alimenticia líquida para rumiantes y métodos para prepararla
AR097517A1 (es) Composiciones antitranspirantes con hidroxialquilurea
MX2017002660A (es) Composiciones mejoradas y metodos para complejos de borocarbohidrato.